Who owns MADRIGAL PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MDGL from SEC Form 13F filings across 441 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 441 institutions disclosed 22.0M shares of MADRIGAL PHARMACEUTICALS, INC. worth $11.11B — about 75.3% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
441
13F holders
$11.11B
value, 2026 filers
75.3%
of shares outstanding (22.0M sh)
83
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MDGL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 2.1M | $1.08B | 5.1% | 7.3% | 0.0% |
| 2 | Janus Henderson Group Ltd.NEW | 2.0M | $993.9M | 0.4% | 6.7% | new |
| 3 | Avoro Capital Advisors LLC | 1.8M | $923.9M | 9.5% | 6.3% | 0.0% |
| 4 | PAULSON & CO. INC. | 1.5M | $751.7M | 25.8% | 5.1% | +11.3% |
| 5 | BlackRock, Inc. | 1.2M | $624.4M | 0.0% | 4.2% | +3.2% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 928,779 | $468.1M | 0.1% | 3.2% | +12.5% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 846,641 | $426.7M | 0.0% | 2.9% | +1.3% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 761,024 | $383.5M | 0.0% | 2.6% | -2.6% |
| 9 | AQR CAPITAL MANAGEMENT LLC | 636,233 | $320.6M | 0.1% | 2.2% | +3919.9% |
| 10 | STATE STREET CORP | 595,775 | $300.2M | 0.0% | 2% | +13.0% |
| 11 | AMERIPRISE FINANCIAL INC | 448,352 | $226.0M | 0.0% | 1.5% | +93.9% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 368,811 | $185.9M | 0.0% | 1.3% | -1.6% |
| 13 | Polar Capital Holdings Plc | 368,309 | $185.6M | 0.4% | 1.3% | +50.8% |
| 14 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 337,035 | $169.9M | 0.6% | 1.2% | +4.0% |
| 15 | Invesco Ltd. | 313,556 | $158.0M | 0.0% | 1.1% | +4.0% |
| 16 | RTW INVESTMENTS, LP | 312,817 | $157.6M | 1.6% | 1.1% | -84.3% |
| 17 | FMR LLC | 288,739 | $145.5M | 0.0% | 1% | -18.9% |
| 18 | LORD, ABBETT & CO. LLC | 262,975 | $132.5M | 0.4% | 0.9% | -6.6% |
| 19 | Artisan Partners Limited Partnership | 243,022 | $122.5M | 0.2% | 0.8% | +15.6% |
| 20 | FIRST TRUST ADVISORS LP | 204,992 | $103.3M | 0.1% | 0.7% | +934.0% |
| 21 | UBS Group AG | 204,392 | $103.0M | 0.0% | 0.7% | -49.1% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 203,874 | $102.7M | 0.0% | 0.7% | +10.6% |
| 23 | Pictet Asset Management Holding SA | 185,889 | $93.7M | 0.1% | 0.6% | -3.6% |
| 24 | TWO SIGMA INVESTMENTS, LP | 185,547 | $93.5M | 0.1% | 0.6% | +32682.2% |
| 25 | PRICE T ROWE ASSOCIATES INC /MD/ | 182,891 | $92.2M | 0.0% | 0.6% | -2.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.